Announcement PDF Market Announcement 20 June 2024 Radiopharm Theranostics Limited (ASX: RAD) – Trading Halt Description The securities of Radiopharm Theranostics Limited (‘RAD’) will be placed in trading halt at the request of RAD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 24 June 2024 or when the announcement is released to the market. Issued by ASX Compliance 20 June 2024 ASX Limited Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au 20 June 2024 Lisa Banh Senior Adviser, Listings Compliance ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000 Via email: tradinghaltssydney@asx.com.au Dear Lisa Radiopharm Theranostics Limited (ASX: RAD) Request for trading halt In accordance with ASX Listing Rule 17.1, Radiopharm Theranostics Limited (ASX: RAD) (the Company) requests that its securities be placed into an immediate trading halt pending an announcement by the Company in relation to a potential capital raising. The Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on Monday, 24 June 2024, whichever is the earlier. The Company is not aware of any reason why this trading halt request should not be granted or of any other information necessary to inform the market about the trading halt. Please contact me if you require any further information. Yours sincerely Phillip Hains Joint Company Secretary Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889